Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • miaom
    Member
    • Oct 2012
    • 12

    How to set Tophat insert size

    correctly setting 2 parameters in Tophat:
    --mate-inner-dist
    --mate-std-dev
    should be very important, but i have no idea how to set them without running bowtie (or bowtie2) -> samtools -> picard tools first, which seems a little bit redundant for Tophat.

    Does any one have suggestions?
    Thanks in advance!!
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    Those are precisely the options that you apply to the tophat command line to change the expected insert size distribution for Tophat. Tophat takes as arguments the bowtie index (and optionally transcriptome GTF file) together with raw reads in FASTQ format, calling bowtie/bowtie2 internally. You shouldn't need to directly run the other programs in order to use Tophat:

    Code:
    Usage: tophat [options]* <genome_index_base> \
      <reads1_1[,...,readsN_1]> [reads1_2,...readsN_2]
    Perhaps you could rephrase your question. What have you tried (command line is useful), and why do you think it doesn't give you the correct results?
    Last edited by gringer; 12-01-2013, 03:28 PM.

    Comment

    • miaom
      Member
      • Oct 2012
      • 12

      #3
      I think the parameters (--mate-inner-dist, --mate-std-dev) are for Tophat only. Bowtie does not need to specify them.
      Running bowtie can generate SAM files, which contain information about fragment size. Without pre-running bowtie (or maybe tophat), how can I know the values for --mate-inner-dist and --mate-std-dev to feed in Tophat?

      Comment

      • gringer
        David Eccles (gringer)
        • May 2011
        • 845

        #4
        Those are experimental values. You should have a good idea of your paired-end distance before doing any mapping. If you can get a good enough idea of that based on genomic (or transcriptomic) mapping distance by running bowtie, maybe you don't need to be running tophat at all....

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          Yesterday, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:10 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        39 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...